Stakeholders Call on FDA to Clarify Supply Chain Verification Guidance

Drug Industry Daily
A A
Drugmaker and pharmacist groups called on the FDA to amend its draft guidance on supply chain verification systems, saying the draft doesn’t account for the varying conditions at facilities.

To View This Article:

Login

Subscribe To Drug Industry Daily